These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3205320)

  • 1. [Psychiatric complications in the treatment of obesity using fenfluramine].
    Klompenhouwer JL; Stricker BH; van Tilburg AJ; Moleman P; Pepplinkhuizen L
    Ned Tijdschr Geneeskd; 1988 Nov; 132(46):2114-7. PubMed ID: 3205320
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fenfluramine and drug dependence].
    Jorgensen F
    Ugeskr Laeger; 1973 Jan; 135(5):236-8. PubMed ID: 4570417
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of obesity with fenfluramine.
    Schindler H; Bielesz G
    Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenfluramine in the management of obesity.
    Datey KK; Kelkar PN; Pandya RS
    Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychotic episode associated with dexfenfluramine.
    Preval H; Pakyurek AM
    Am J Psychiatry; 1997 Nov; 154(11):1624-5. PubMed ID: 9356579
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind cross-over study of fenfluramine (Ponderax) in obesity.
    Rastogi GK; Sharma PL; Saini GS; Kanen VL
    J Assoc Physicians India; 1972 Nov; 20(11):849-52. PubMed ID: 4570012
    [No Abstract]   [Full Text] [Related]  

  • 8. [Remarkably high number of reports on psychotic reactions after Ponderal therapy].
    Lakartidningen; 1987 Jun; 84(26-27):2289-90. PubMed ID: 3613770
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypotensive effect of fenfluramine in the treatment of obesity.
    Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenfluramine withdrawal and epilepsy.
    Davidson DL; Mawdsley C; Campbell C; Munro JF
    Postgrad Med J; 1975; 51 Suppl 1():174-6. PubMed ID: 1219675
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of fenfluramine (with ad libitum food intake) with 1,000 calorie diet in obesity.
    Hooper AC
    J Ir Med Assoc; 1972 Jan; 65(2):35-7. PubMed ID: 5058787
    [No Abstract]   [Full Text] [Related]  

  • 13. Fenfluramine-associated hypertension.
    Mabadeje AF
    West Afr J Pharmacol Drug Res; 1975 Dec; 2(2):145-52. PubMed ID: 1233823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hypertension following use of fenfluramine for obesity].
    Maesen BL; Snijder RJ; Stricker BH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(50):2500-2. PubMed ID: 7800076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged action fenfluramine in general practice.
    Owen JH
    Br J Clin Pract; 1975 Jan; 29(1):13-14. PubMed ID: 1095043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fenfluramine in the treatment of obesity].
    Sedgwick JP
    Vie Med Can Fr; 1973 Mar; 2(3):243-7. PubMed ID: 4707493
    [No Abstract]   [Full Text] [Related]  

  • 17. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study].
    Haug E; Myklebust R
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of the risk-factor overweight in orthopedics].
    Krause W
    Med Monatsschr; 1973 Sep; 27(9):421-3. PubMed ID: 4768202
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects and indications of fenfluramine in the treatment of obesity].
    Vignati E
    Vie Med Can Fr; 1973; 2(2):166-70. PubMed ID: 4706701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.